(Q37857331)

24 August 2017

1 reference

title

Linezolid, the first oxazolidinone antibacterial agent (English)

1 reference

24 August 2017

1 reference

Karen L Leach

1

1 reference

24 August 2017

Steven J Brickner

series ordinal

2

1 reference

24 August 2017

Mark C Noe

series ordinal

3

1 reference

24 August 2017

Paul F Miller

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Annals of the New York Academy of Sciences

24 August 2017

1 reference

24 August 2017

1222

1 reference

24 August 2017

49-54

1 reference

The discovery of linezolid, the first oxazolidinone antibacterial agent.

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Newer antibacterial drugs for a new century

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

United States resistance surveillance results for linezolid (LEADER Program for 2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Newer developments in the treatment of Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.05962.X

10.1111/J.1749-6632.2011.05962.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference